Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.
作者信息
Miri Seyed Mohammad, Noorbakhsh Farshid, Mohebbi Seyed Reza, Ghaemi Amir
机构信息
Department of Chemistry, Sharif University of Technology, Tehran, Iran.
Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
J Med Virol. 2020 Nov;92(11):2257-2259. doi: 10.1002/jmv.26069. Epub 2020 Jun 9.
Abstract
摘要
相似文献
1
Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.儿童中无症状或轻症新冠病毒感染的患病率更高，说法及线索。
J Med Virol. 2020 Nov;92(11):2257-2259. doi: 10.1002/jmv.26069. Epub 2020 Jun 9.
2
The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?无症状 SARS-CoV-2 感染的免疫学：关键问题是什么？
Nat Rev Immunol. 2021 Dec;21(12):762-768. doi: 10.1038/s41577-021-00631-x. Epub 2021 Oct 19.
3
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.2021 年 5 月波兰人群中对 SARS-CoV-2 具有免疫力的隐匿人群。
PLoS One. 2022 Feb 3;17(2):e0253638. doi: 10.1371/journal.pone.0253638. eCollection 2022.
4
Sex-based differences in severity and mortality in COVID-19.性别差异与 COVID-19 的严重程度和死亡率。
Rev Med Virol. 2021 Nov;31(6):e2223. doi: 10.1002/rmv.2223. Epub 2021 Mar 1.
5
COVID-19: Loss of bridging between innate and adaptive immunity?COVID-19：固有免疫与适应性免疫之间的桥梁缺失？
Med Hypotheses. 2020 Nov;144:109861. doi: 10.1016/j.mehy.2020.109861. Epub 2020 May 23.
6
Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.旧疫苗应对新感染：利用先天免疫控制 COVID-19 并预防未来的大流行。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2101718118.
7
An increasing public health burden arising from children infected with SARS-CoV2: A systematic review and meta-analysis.由于感染 SARS-CoV2 的儿童而导致的公共卫生负担日益加重：系统评价和荟萃分析。
Pediatr Pulmonol. 2020 Dec;55(12):3487-3496. doi: 10.1002/ppul.25008. Epub 2020 Sep 25.
8
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.代谢相关脂肪性肝病中先天性和适应性免疫的改变及其对COVID-19严重程度的影响。
Front Immunol. 2021 Mar 30;12:651728. doi: 10.3389/fimmu.2021.651728. eCollection 2021.
9
Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.COVID-19 中的性别差异：候选途径、ACE2 的遗传学和性激素。
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H296-H304. doi: 10.1152/ajpheart.00755.2020. Epub 2020 Dec 4.
10
Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity.感染 SARS-CoV-2 期间出现 COVID-19 症状定义了体液免疫的衰减。
Front Immunol. 2021 Aug 16;12:722027. doi: 10.3389/fimmu.2021.722027. eCollection 2021.
引用本文的文献
1
Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children.广泛的新冠病毒检测揭示了学龄儿童中BA.1/BA.2的无症状感染率及报告不足的情况。
Can Commun Dis Rep. 2023 Apr 1;49(4):155-165. doi: 10.14745/ccdr.v49i04a08.
2
Six-month outcome of multisystem inflammatory syndrome with persistent neutropenia in neonate: A case report and review of literature.新生儿多系统炎症综合征伴持续性中性粒细胞减少症的6个月结局：1例病例报告及文献复习
J Family Med Prim Care. 2023 Nov;12(11):2963-2966. doi: 10.4103/jfmpc.jfmpc_690_23. Epub 2023 Nov 21.
3
The asymptomatic ocular surface reservoir of coronavirus disease-19 in infants and retinopathy of prematurity screening during the pandemic.婴儿中2019冠状病毒病的无症状眼表储存库及大流行期间的早产儿视网膜病变筛查
Taiwan J Ophthalmol. 2023 Aug 11;13(3):323-328. doi: 10.4103/tjo.TJO-D-23-00052. eCollection 2023 Jul-Sep.
4
Acute hepatitis with non-alcoholic fatty liver disease-expanding clinical spectrum in COVID-19 exposed children: case report and review of literature.新冠病毒感染儿童中急性肝炎合并非酒精性脂肪性肝病——临床谱扩大：病例报告及文献综述
Sudan J Paediatr. 2023;23(1):91-97. doi: 10.24911/SJP.106-1636877693.
5
The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups.免疫在SARS-CoV-2感染发病机制及不同年龄组COVID-19疫苗所产生的保护作用中的角色。
Pathogens. 2023 Feb 15;12(2):329. doi: 10.3390/pathogens12020329.
6
A Retrospective Population Study of 385 191 Positive Real-Time Reverse Transcription-Polymerase Chain Reaction Tests For SARS-CoV-2 from a Single Laboratory in Katowice, Poland from April 2020 to July 2022.一项针对 2020 年 4 月至 2022 年 7 月期间来自波兰卡托维兹的单个实验室的 385191 例 SARS-CoV-2 实时逆转录-聚合酶链反应检测阳性的回顾性人群研究。
Med Sci Monit. 2023 Jan 2;29:e938872. doi: 10.12659/MSM.938872.
7
Clinical characteristics and outcomes of confirmed COVID-19 patients in the early months of the pandemic in Tanzania: a multicenter cohort study.坦桑尼亚疫情初期确诊的2019冠状病毒病患者的临床特征与结局：一项多中心队列研究
IJID Reg. 2022 Mar;2:118-125. doi: 10.1016/j.ijregi.2021.12.010. Epub 2022 Jan 6.
8
Pediatric transplantation during the COVID-19 pandemic.新冠疫情期间的儿科移植
World J Transplant. 2022 May 18;12(5):88-99. doi: 10.5500/wjt.v12.i5.88.
9
The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment.2020 - 2021年儿童和青少年中的新型冠状病毒肺炎疫情：了解临床表现、传播模式、病毒载量、诊断和治疗
J Glob Health. 2021 Dec 25;11:01010. doi: 10.7189/jogh.11.01010. eCollection 2021.
10
Assessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: a national derivation and validation cohort study.评估症状评分预测尼日利亚 COVID-19 阳性的能力：一项全国推导和验证队列研究。
BMJ Open. 2021 Sep 3;11(9):e049699. doi: 10.1136/bmjopen-2021-049699.
本文引用的文献
1
Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.SARS-CoV-2 受体 ACE2 基因表达和调控的个体差异。
Aging Cell. 2020 Jul;19(7). doi: 10.1111/acel.13168. Epub 2020 Jun 19.
2
An Update on Current Therapeutic Drugs Treating COVID-19.治疗新型冠状病毒肺炎的当前治疗药物最新情况
Curr Pharmacol Rep. 2020;6(3):56-70. doi: 10.1007/s40495-020-00216-7. Epub 2020 May 11.
3
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.儿童感染 SARS-CoV-2 的特征及粪便中持续存在病毒的潜在证据。
Nat Med. 2020 Apr;26(4):502-505. doi: 10.1038/s41591-020-0817-4. Epub 2020 Mar 13.
4
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.迫切需要开展针对新型冠状病毒肺炎的抗肿瘤坏死因子疗法试验。
Lancet. 2020 May 2;395(10234):1407-1409. doi: 10.1016/S0140-6736(20)30858-8. Epub 2020 Apr 9.
5
Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections.减少嗜老年菌和嗜老年病毒感染中的合并症、感染率、严重程度及致死率的老年保护和衰老修复策略。
Aging (Albany NY). 2020 Mar 31;12(8):6492-6510. doi: 10.18632/aging.102988.
6
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
7
BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.BCG 诱导的交叉保护和训练免疫的发展：对疫苗设计的启示。
Front Immunol. 2019 Nov 29;10:2806. doi: 10.3389/fimmu.2019.02806. eCollection 2019.
8
Age-dependent differences in pulmonary host responses in ARDS: a prospective observational cohort study.急性呼吸窘迫综合征中肺部宿主反应的年龄依赖性差异：一项前瞻性观察队列研究。
Ann Intensive Care. 2019 May 14;9(1):55. doi: 10.1186/s13613-019-0529-4.
9
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity.BCG 疫苗接种通过诱导与训练有素的免疫相关的细胞因子来保护人类免受实验性病毒感染。
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5. doi: 10.1016/j.chom.2017.12.010.
10
Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus.血管紧张素转换酶2抑制呼吸道合胞病毒诱导的肺损伤。
Sci Rep. 2016 Jan 27;6:19840. doi: 10.1038/srep19840.
Zotero 插件